Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant
Authors:
- Tatu J MäkinenTMTatu J Mäkinen
- Esa SuokasESEsa Suokas
- Minna VeirantoMVMinna Veiranto
- Jari JalavaJJJari Jalava
- Pertti TörmäläPTPertti Törmälä
- Hannu T AroHAHannu T Aro
Open Access
- 1 January 2008
- journal article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 79 (2) , 295-301
Abstract
Antibiotic-releasing bioresorbable implants are used for local treatment of bone infections, but most drug delivery systems release antibiotic for too short a time. We used pellets (0.9 x 1.0 mm) made of bioabsorbable poly(DL) lactic acid matrix, ciprofloxacin (7.3 +/- 0.4 wt%), and bioactive glass microspheres of 90-125 microm (29.3 +/- 0.2 wt%). The ciprofloxacin release and antibacterial activity was measured in elution tests in vitro and local tissue concentrations were measured in rabbits. In elution tests in vitro, the therapeutic level (> 2 microg/mL) of ciprofloxacin was achieved within 6 h of the start of the test, and it was maintained for up to 300 days. The antibacterial activity of the antibiotic released from sterilized composites was similar to that of the unprocessed ciprofloxacin. In vivo measurements showed high local tissue concentrations (16-86 micrg/g of bone tissue) for 3 months. Compared to previous experiments on two-component polymeric matrices (PLGA or PDLLA) with ciprofloxacin alone, adding bioactive glass microspheres into the composite resulted in morphological changes that facilitated fluid intrusion into the microstructure and quickened ciprofloxacin release. This type of composition of implant may fulfill the requirements of bone infection therapy, for sustained local release of the selected antibiotic over several months.Keywords
This publication has 18 references indexed in Scilit:
- In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatmentJournal of Biomedical Materials Research Part A, 2006
- In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect fillerJournal of Antimicrobial Chemotherapy, 2005
- Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practiceThe Journal of Bone and Joint Surgery. British volume, 2005
- Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due toStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Antibiotic Microspheres: Preliminary Testing for Potential Treatment of OsteomyelitisClinical Orthopaedics and Related Research, 2003
- The Classic: A Clinical Staging System for Adult OsteomyelitisClinical Orthopaedics and Related Research, 2003
- Lactic Acid Polymers as Biodegradable Carriers of Fluoroquinolones: An In Vitro StudyAntimicrobial Agents and Chemotherapy, 1999
- Effect of ciprofloxacin on the proliferation of osteoblast‐like MG‐63 human osteosarcoma cells in vitroJournal of Orthopaedic Research, 1998
- Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-upJournal of Antimicrobial Chemotherapy, 1997
- Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model.Journal of Bone and Joint Surgery, 1994